LM Advisors »

Abcellera Biologics shares owned by LM Advisors

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by LM Advisors from 13F filings

Historical chart of LM Advisors investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by LM Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by LM Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1k 200 5.71

More positions owned by LM Advisors

Amazon (AMZN)
Invesco Exch Trd Slf Idx Fd Rusl 1000 Dynm Etf (OMFL)
Vanguard Index Fds S&p 500 Etf Etf (VOO)
Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
Apple (AAPL)
Alphabet Inc Cap Stk Cl C CL C (GOOG)
Vanguard Specialized Funds Div App Etf Etf (VIG)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 Etf
salesforce (CRM)
Vanguard World Fds Health Car Etf Etf (VHT)
Vanguard Index Fds Total Stk Mkt Etf (VTI)
Alphabet Inc Cap Stk Cl A Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl A Cl A (BRK.A)
Costco Wholesale Corporation (COST)

View all positions for LM Advisors

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics